Current treatment options for intracerebral hemorrhage

Fred Rincon, Stephan A. Mayer

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Intracerebral hemorrhage (ICH) remains the least treatable form of stroke. Despite ongoing attempts to find effective interventions based on the physiopathologic understanding of this disease, evidence-based medical therapies for ICH are limited to recommendations on blood pressure (BP) reduction, intracranial pressure monitoring, osmotherapy with adequate fluid resuscitation, fever and glycemic control, and seizure prophylaxis. Although the value of surgical treatment remains in doubt because of the negative results of the International Surgical Trial in Intracerebral Haemorrhage (STICH), a subgroup analysis of this study suggested better outcomes among patients with superficial hematomas who underwent surgical evacuation, supporting the ongoing STICH-II trial. Other approaches currently under study include ultra-early hemostatic therapy and BP reduction, thrombolytic therapy for intraventricular hemorrhage, and minimally invasive surgical approaches.

Original languageEnglish
Pages (from-to)229-240
Number of pages12
JournalCurrent Treatment Options in Cardiovascular Medicine
Issue number3
StatePublished - Jun 2008
Externally publishedYes


Dive into the research topics of 'Current treatment options for intracerebral hemorrhage'. Together they form a unique fingerprint.

Cite this